Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting at the Hawaiian Convention Center suggest that correctly occluded left atrial appendages (LAAs) could present maximal reduction in left atrial (LA) flow stasis and thrombogenicity, offering a clinical goal for the procedure in patients with atrial fibrillation.

Production of three life-sized left atrial phantoms 


April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting at the Hawaiian Convention Center suggest that correctly occluded left atrial appendages (LAAs) could present maximal reduction in left atrial (LA) flow stasis and thrombogenicity, offering a clinical goal for the procedure in patients with atrial fibrillation. 

Pointing out the paucity of knowledge in atrial fibrillation (AF) populations regarding the actual flow dynamic changes before and after percutaneous left atrial appendage occlusion (LAAO), “we aimed to evaluate LA flow dynamics for pre-occluded, correctly occluded, and incorrectly occluded LAAs in patients with AF via four-dimensional (4D) flow MRI and 3D printed phantoms,” said Min Jae Cha from the department of radiology at Chung-Ang University Hospital in Seoul, South Korea. 


In this ARRS Annual Meeting Summa Cum Laude award-winning Online Poster, life-sized LA phantoms of an 86-year-old patient with persistent AF were 3D printed from cardiac CT images. Setting a custom-made, closed-loop flow circuit, a pump delivered pulsatile pulmonary venous flow. Using a 3-T scanner (Philips Achieva TX), 4D flow MRI was obtained, then analyzed via MATLAB-based software. Flow metrics associated with blood stasis and thrombogenicity—stasis volume defined by velocity threshold (|V| < 3 cm/s), time-averaged wall shear stress (WSS), and endothelial cell activation potential (ECAP)—were compared among three conditions. 

According to Cha et al., different spatial distributions, orientations, and magnitudes of flow were directly visualized within the three LA phantoms using 4D flow MRI. The time-averaged volume and percentage of LA flow stasis were consistently minimized in the correctly occluded model (70.82 ml, 38.97%), followed by the incorrectly occluded (73.17 ml, 39.02%) and pre-procedural (79.11 ml, 39.71%) models. 

Additionally, the pre-occluded model was associated with the lowest surface-and-time-averaged WSS (0.048 Pa), followed by incorrectly (0.059 Pa) and correctly (0.072 Pa) occluded models. Conversely, ECAP was lowest in the correctly occluded model (4.004 Pa-1), followed by the incorrectly- (4.792 Pa-1) and pre-occluded (5.861 Pa-1) models. 

For more information: www.arrs.org 


Find more ARRS23 Annual Meeting coverage here 


Related Content

News | Cardiac Imaging

May 20, 2025 — Royal Philips has launched the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter ...

Time May 27, 2025
arrow
News | Pediatric Imaging

May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric ...

Time May 20, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
Subscribe Now